Accendra Health Amends 8-K, Adds Consulting Agreement with Edward Pesicka

What Happened
Accendra Health, Inc. (ACH) filed Amendment No. 1 to a previously filed Form 8-K on September 28, 2026 (Accession No. 0001104659-26-111408) to supplement its prior disclosure. The amendment reports items under Item 5.02 (departure/election of directors or certain officers) and Item 9.01 (financial statements and exhibits) and attaches a Consulting Agreement dated September 28, 2026 between the company and Edward Pesicka as Exhibit 10.1. The filing is signed by Heath H. Galloway, Executive Vice President, General Counsel and Corporate Secretary.

Key Details

• Filing: Form 8-K/A (Amendment No. 1) filed September 28, 2026.
• Items reported: Item 5.02 (departure/election of directors or certain officers) and Item 9.01 (exhibits).
• Exhibit added: Consulting Agreement dated September 28, 2026 between Accendra Health and Edward Pesicka (Exhibit 10.1).
• Signed by: Heath H. Galloway, EVP, General Counsel & Corporate Secretary.

Why It Matters
This amendment updates the company’s prior disclosure about officer/director changes and provides the actual consulting agreement as an exhibit. Investors should review the agreement and the original 8-K to understand any new contractual obligations, compensation, role or transition arrangements tied to company leadership or governance. The exhibit may contain terms (duration, fees, duties) that could affect future operating expenses or management continuity.